Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity

  1. Xue-Song Zhang  Is a corresponding author
  2. Jackie Li
  3. Kimberly A Krautkramer
  4. Michelle Badri
  5. Thomas Battaglia
  6. Timothy C Borbet
  7. Hyunwook Koh
  8. Sandy Ng
  9. Rachel A Sibley
  10. Yuanyuan Li
  11. Wimal Pathmasiri
  12. Shawn Jindal
  13. Robin R Shields-Cutler
  14. Ben Hillmann
  15. Gabriel A Al-Ghalith
  16. Victoria E Ruiz
  17. Alexandra Livanos
  18. Angelique Wout
  19. Nabeetha Nagalingam
  20. Arlin B Rogers
  21. Susan Jenkins Sumner
  22. Dan Knights
  23. John M Denu
  24. Huilin Li
  25. Kelly V Ruggles
  26. Richard Bonneau
  27. Anthony R Williamson
  28. Marcus Rauch
  29. Martin J Blaser  Is a corresponding author
  1. New York University Langone Medical Center, United States
  2. University of Wisconsin School of Medicine and Public Health, United States
  3. University of North Carolina at Chapel Hill School of Public Health, United States
  4. University of Minnesota, United States
  5. Janssen Pharmaceutical Companies of Johnson and Johnson, United Kingdom
  6. Tufts University, United States
  7. New York University, United States

Abstract

The early-life intestinal microbiota plays a key role in shaping host immune system development. We found that a single early-life antibiotic course (1PAT) accelerated type 1 diabetes (T1D) development in male NOD mice. The single course had deep and persistent effects on the intestinal microbiome, leading to altered cecal, hepatic, and serum metabolites. The exposure elicited sex-specific effects on chromatin states in the ileum and liver and perturbed ileal gene expression, altering normal maturational patterns. The global signature changes included specific genes controlling both innate and adaptive immunity. Microbiome analysis revealed four taxa each that potentially protect against or accelerate T1D onset, that were linked in a network model to specific differences in ileal gene expression. This simplified animal model reveals multiple potential pathways to understand pathogenesis by which early-life gut microbiome perturbations alter a global suite of intestinal responses, contributing to the accelerated and enhanced T1D development.

Data availability

RNA-Seq data that support the findings of this study have been deposited in ArrayExpress database (www.ebi.ac.uk/arrayexpress) with the accession code E-MTAB-6826 (https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6826). 16S rRNA data has been deposited in QIITA (https://qiita.ucsd.edu/) with the identifier 11242 (https://qiita.ucsd.edu/study/description/11242). Ileal NanoString data have been deposited in NCBI's Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series accession number, GSE101721 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE10172). Shotgun metagenomics data have been deposited in the European Nucleotide Archive (ENA) (https://www.ebi.ac.uk/metagenomics/) under the accession number, PRJEB26585 (http://www.ebi.ac.uk/ena/data/view/PRJEB26585).Metabolomics data have been deposited at the NIH Common Fund Metabolomics Workbench (www.metabolomicsworkbench.org; doi: 10.21228/M8C39R)

The following data sets were generated

Article and author information

Author details

  1. Xue-Song Zhang

    Department of Medicine, New York University Langone Medical Center, New York, United States
    For correspondence
    xuesong.zhang@nyumc.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5080-0098
  2. Jackie Li

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1376-6692
  3. Kimberly A Krautkramer

    Department of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Michelle Badri

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Thomas Battaglia

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Timothy C Borbet

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Hyunwook Koh

    Department of Population Health, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Sandy Ng

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Rachel A Sibley

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Yuanyuan Li

    Nutrition Research Institute, University of North Carolina at Chapel Hill School of Public Health, Kannapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Wimal Pathmasiri

    Nutrition Research Institute, University of North Carolina at Chapel Hill School of Public Health, Kannapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Shawn Jindal

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Robin R Shields-Cutler

    BioTechnology Institute, Computer Science and Engineering, University of Minnesota, St Paul, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Ben Hillmann

    BioTechnology Institute, Computer Science and Engineering, University of Minnesota, St Paul, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Gabriel A Al-Ghalith

    BioTechnology Institute, Computer Science and Engineering, University of Minnesota, St Paul, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Victoria E Ruiz

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Alexandra Livanos

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Angelique Wout

    Janssen Prevention Center London, Janssen Pharmaceutical Companies of Johnson and Johnson, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  19. Nabeetha Nagalingam

    Janssen Prevention Center London, Janssen Pharmaceutical Companies of Johnson and Johnson, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  20. Arlin B Rogers

    Department of Biomedical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, United States
    Competing interests
    The authors declare that no competing interests exist.
  21. Susan Jenkins Sumner

    Nutrition Research Institute, University of North Carolina at Chapel Hill School of Public Health, Kannapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Dan Knights

    BioTechnology Institute, Computer Science and Engineering, University of Minnesota, St Paul, United States
    Competing interests
    The authors declare that no competing interests exist.
  23. John M Denu

    Department of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  24. Huilin Li

    Department of Population Health, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  25. Kelly V Ruggles

    Department of Medicine, New York University Langone Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  26. Richard Bonneau

    Center for Data Science, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  27. Anthony R Williamson

    Janssen Prevention Center London, Janssen Pharmaceutical Companies of Johnson and Johnson, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  28. Marcus Rauch

    Janssen Prevention Center London, Janssen Pharmaceutical Companies of Johnson and Johnson, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  29. Martin J Blaser

    Department of Medicine, New York University Langone Medical Center, New York, United States
    For correspondence
    Martin.Blaser@nyumc.org
    Competing interests
    The authors declare that no competing interests exist.

Funding

Janssen Labs London (15-A0-00-00-0039-29-01)

  • Martin J Blaser

Fondation Leducq (-33.17CVD01)

  • Martin J Blaser

National Institutes of Health (R01DK110014)

  • Huilin Li

National Institutes of Health (R37GM059785)

  • John M Denu

National Institutes of Health (5T35DK007421)

  • Sandy Ng
  • Rachel A Sibley

National Institutes of Health (F30DK108494)

  • Kimberly A Krautkramer

C & D fund

  • Martin J Blaser

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (160623) of the New York University Langone Medical Center.

Copyright

© 2018, Zhang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,378
    views
  • 812
    downloads
  • 80
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Xue-Song Zhang
  2. Jackie Li
  3. Kimberly A Krautkramer
  4. Michelle Badri
  5. Thomas Battaglia
  6. Timothy C Borbet
  7. Hyunwook Koh
  8. Sandy Ng
  9. Rachel A Sibley
  10. Yuanyuan Li
  11. Wimal Pathmasiri
  12. Shawn Jindal
  13. Robin R Shields-Cutler
  14. Ben Hillmann
  15. Gabriel A Al-Ghalith
  16. Victoria E Ruiz
  17. Alexandra Livanos
  18. Angelique Wout
  19. Nabeetha Nagalingam
  20. Arlin B Rogers
  21. Susan Jenkins Sumner
  22. Dan Knights
  23. John M Denu
  24. Huilin Li
  25. Kelly V Ruggles
  26. Richard Bonneau
  27. Anthony R Williamson
  28. Marcus Rauch
  29. Martin J Blaser
(2018)
Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity
eLife 7:e37816.
https://doi.org/10.7554/eLife.37816

Share this article

https://doi.org/10.7554/eLife.37816

Further reading

  1. A dose of antibiotics early in life may increase the risk of type 1 diabetes.

    1. Immunology and Inflammation
    Yue Yang, Bin Huang ... Fangfang Zhang
    Research Article

    Adipose tissue inflammation is now considered to be a key process underlying metabolic diseases in obese individuals. However, it remains unclear how adipose inflammation is initiated and maintained or the mechanism by which inflammation develops. We found that microRNA-802 (Mir802) expression in adipose tissue is progressively increased with the development of dietary obesity in obese mice and humans. The increasing trend of Mir802 preceded the accumulation of macrophages. Adipose tissue-specific knockout of Mir802 lowered macrophage infiltration and ameliorated systemic insulin resistance. Conversely, the specific overexpression of Mir802 in adipose tissue aggravated adipose inflammation in mice fed a high-fat diet. Mechanistically, Mir802 activates noncanonical and canonical NF-κB pathways by targeting its negative regulator, TRAF3. Next, NF-κB orchestrated the expression of chemokines and SREBP1, leading to strong recruitment and M1-like polarization of macrophages. Our findings indicate that Mir802 endows adipose tissue with the ability to recruit and polarize macrophages, which underscores Mir802 as an innovative and attractive candidate for miRNA-based immune therapy for adipose inflammation.